SABCS15 Wedesday Press Conference
Moderator: SABCS Co-director Virginia Kaklamani, MD, leader of the Breast Cancer Program at the Cancer Therapy & Research Center and professor of medicine at the UT Health Science Center San Antonio Capecitabine Improved Outcomes for Breast Cancer Patients With Residual Disease After Presurgery Chemotherapy; Women With Luminal A Subtype of Breast Cancer Did Not Benefit From Adjuvant Chemotherapy; Denosumab Improves Disease-free Survival for Postmenopausal Patients With HR-positive Breast Cancer; and Pathologic Complete Response to Presurgery Chemotherapy Improves Survival For Patients With Triple-negative Breast Cancer.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of AACR Scientific Podcasts?
This episode is 1 hour and 3 minutes long.
When was this AACR Scientific Podcasts episode published?
This episode was published on December 9, 2015.
Can I download this AACR Scientific Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.